Latest Adult stem cell Stories
Connie K. Ho for redOrbit.com – Your Universe Online 20,000,000. This is the number of peripheral artery disease patients Pluristem Therapeutics, a placenta-based cell therapy company, is working to assist. The company recently released information regarding the effectiveness of cell therapy with intramuscular delivery. To begin, Pluristem uses stem cells from the human placenta and has created a manufacturing process that produces enough cells to treat 10,000 patients from one...
A team of scientists at the New York Stem Cell Foundation (NYSCF) Laboratory have developed a cell-based model of Alzheimer’s disease (AD) by reprogramming skin cells of Alzheimer’s patients to become brain cells that are affected in Alzheimer's A team of scientists at The New York Stem Cell Foundation (NYSCF) Laboratory led by Scott Noggle, PhD, NYSCF–Charles Evans Senior Research Fellow for Alzheimer's Disease, has developed the first cell-based model of Alzheimer's disease (AD) by...
Protocol may open new avenues for cell-replacement therapies for neurological conditions For more than 20 years, doctors have been using cells from blood that remains in the placenta and umbilical cord after childbirth to treat a variety of illnesses, from cancer and immune disorders to blood and metabolic diseases. Now, scientists at the Salk Institute for Biological Studies have found a new way-using a single protein, known as a transcription factor-to convert cord blood (CB) cells...
JUPITER, Fla., July 16, 2012 /PRNewswire/ -- BioRestorative Therapies, Inc. ("BRT") (OTCQB: BRTX) announced today that its Stem Pearls® subsidiary has launched its new website, enabling its products to be purchased on the company's website at www.stempearls.com or by calling (855) 77-PEARL. Formulated around an award winning ingredient, the Stem Pearls® product line uses plant stem cells known for their regenerative and anti-aging properties. The star product, Apple Stem Cell...
CLEVELAND, July 16, 2012 /PRNewswire/ -- Juventas Therapeutics, a clinical-stage regenerative medicine company, announced today that it has closed a $22.2 million Series B financing that was co-led by Triathlon Medical Venture Partners and New Science Ventures. All previous venture firms, including Fletcher Spaght Ventures, Reservoir Venture Partners and Early Stage Partners participated in the round. Also joining the syndicate are new investors Takeda Ventures, Venture Investors,...
Animal Cell Therapies, Inc. a veterinarian regenerative medicine company is pleased to announce the appointment of Leo T. Furcht, M.D. to its Board of Directors. (PRWEB) July 13, 2012 Dr. Furcht, Department Chair of the Laboratory Medicine and Pathology at the University of Minnesota, brings a wealth of scientific and commercial experience from the field of regenerative medicine. His work includes co-author of the book The Stem Cell Dilemma and holding several key patents in the adult...
In the July 6 issue of Cell Stem Cell, researchers at the University of California, San Diego School of Medicine describe how human epidermal progenitor cells and stem cells control transcription factors to avoid premature differentiation, preserving their ability to produce new skin cells throughout life. The findings provide new insights into the role and importance of exosomes and their targeted gene transcripts, and may help point the way to new drugs or therapies for not just skin...
Connie K. Ho for redOrbit.com – Your Universe Online Stem cell research is gaining headway, but is still controversial. Scientists hope that a new discovery regarding stem cells from amniotic fluid will pave the way to an alternative option. A collaborative group of researchers recently discovered that stem cells in amniotic fluid can be changed into a more flexible state, which could possibly open another option to embryonic stem cells. The study was recently published in the journal...
SHENZHEN, China, July 3, 2012 /PRNewswire-Asia/ -- A study conducted by Beike Biotechnology Company (http://www.beikebiotech.com) in conjunction with physicians and researchers at two Chinese hospitals, documents the effectiveness of cord blood-derived stem cells in treating primary biliary cirrhosis (PBC). The study, which was published in the April 2012 issue of the Stem Cell Discovery, was the first of its kind. Researchers noted that additional clinical trials would be...
(Ivanhoe Newswire) -- Parkinson's disease is a disorder of the brain that leads to shaking, difficulty with walking, movement, and coordination. With 50,000 new cases reported every year it is one of the most common nervous system disorders of the elderly. Researchers are attempting to develop stem cell therapy to replace cells causing this disease. In Parkinson's disease, the loss of dopamine-producing cells in the midbrain causes well-characterized motor symptoms. Though embryonic stem...
